Demant's hearing implant division struggled with recalls and pandemic pressure
From the second half of 2022, Demant will no longer sell hearing implants. The company’s implant division, Oticon Medical, has been challenged by past recalls and the pandemic situation, says CEO Søren Nielsen.
by marketwire, translated by daniel pedersen
Hearing aid manufacturer Demant has just announced its intention to divest its business division that has long been outwardly signaled to be one of its strategically important areas.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Demant to divest hearing implant division to Cochlear
For subscribers
Demant lost ground at Veterans Affairs in March
For subscribers
.jpg&w=384&q=75)
